Brief: Inhibikase Therapeutics Prices Public Offering Of 46 Million Shares At $1.45 Per Share
21/11/2025 02:57
Nov 20 (Reuters) - Inhibikase Therapeutics Inc IKT.O: INHIBIKASE THERAPEUTICS ANNOUNCES PRICING OF $100 MILLION PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS INHIBIKASE THERAPEUTICS INC - PRICES PUBLIC OFFERING OF 46 MILLION SHARES AT $1.45 PER SHARE Source text: ID:nGNX6cQQC1 Further company coverage: IKT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inhibikase Therapeutics
See all newsBrief: Inhibikase Therapeutics Appoints Scott Wasserman To Board Of Directors
Inhibikase Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Inhibikase Q2 net loss widens on higher R&D, SG&A costs
Inhibikase Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Brief: Inhibikase Therapeutics Prices Public Offering Of 46 Million Shares At $1.45 Per Share